Ohno, Mikiko
Shiomi, Hiroki
Baba, Osamu
Yano, Mariko
Aizawa, Takanori
Nakano-Matsumura, Yukiko
Yamagami, Shintaro
Kato, Masashi
Ohya, Masanobu
Chen, Po-Min
Nagao, Kazuya
Ando, Kenji
Yokomatsu, Takafumi
Kadota, Kazushige
Kouchi, Ichiro
Inada, Tsukasa
Valentine, Cindy
Kitagawa, Takahiro
Kurokawa, Masato
Ohtsuru, Shigeru
Morimoto, Takeshi
Kimura, Takeshi
Nishi, Eiichiro http://orcid.org/0000-0002-8188-8026
Funding for this research was provided by:
Takeda Science Foundation
Naito Foundation
NOVARTIS Foundation (Japan) for the Promotion of Science
Kobayashi International Scholarship Foundation
Japan Society for the Promotion of Science (20H03449, 20K08445, 20K21523, 22K19428, 23K07550)
Murata Science Foundation
Article History
Received: 26 May 2023
Accepted: 6 December 2023
First Online: 17 January 2024
Declarations
:
: The authors declare that they have no competing interests.
: The Nardi-ACS Study was approved by the local Ethics Committee of the Graduate School and Faculty of Medicine, Kyoto University (R0653) and five participating hospitals (Kokura Memorial Hospital, Mitsubishi Kyoto Hospital, Kurashiki Central Hospital, Saiseikai Noe Hospital, and Osaka Red Cross Hospital). In addition, the Nardi-ACS Study has been registered in the UMIN Clinical Trials Registry (UMIN000024577). All participants provided their written informed consent for participation and data collection from general practitioners.
: Not applicable.